相关实验视频

Updated: Jul 16, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

超高效的放射性免疫疗法用于重编程缺氧和免疫抑制瘤微环境,并提供持久的先天免疫记忆

Jichun Yang¹, Chong Zhang², Xiaohui Chen²

¹Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing, 400044, PR China.

|September 9, 2023

概括

这项研究介绍了一种使用细胞外囊泡 (EV) 传递空心二氧化 (MnO2) 和甲的新型纳米平台,显著增强放射治疗 (RT) 并激活天生的免疫力,以改善癌症治疗.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗癌症治疗

背景情况:

传统的放射敏感剂在瘤微环境 (TME) 调节和细胞吸收方面存在局限性.
开发用于增强放射治疗 (RT) 和免疫激活的有效策略对于癌症治疗至关重要.

研究的目的:

开发一种超高效的RT策略,使用含有甲 (Met@HMnER) 的细胞外囊泡 (EVs) 封装的空心二氧化 (MnO2).
为了增强生物屏障的透,并触发先天性免疫激活,以改善癌症治疗.

主要方法:

合成的Met@HMnER,一个装有metformin的EVs封装的空心MnO2纳米平台.
通过形态控制和细胞呼吸抑制评估RT增强.
通过cGAS-STING通路评估生物屏障透和NK细胞激活.
在远端转移和现场复发的体内模型中验证了免疫能力.

主要成果:

与传统固体MnO2相比,Met@HMnER证明了显著的RT增强.
针对目标修改的电动汽车表现出增强的甲胺负载和生物屏障透.
纳米平台通过cGAS-STING通路诱导NK细胞的持久的先天免疫激活.
在体内研究证实了针对瘤转移和复发的增强免疫能力.

结论:

这种新型纳米平台为临床癌症治疗中的协同和强大的先天免疫提供了一个有希望的战略.
Met@HMnER系统克服了传统放射敏感剂的局限性,为先进的癌症治疗铺平了道路.

关键词:

空心MnO (((2)) 是一个空心.天生的免疫效应产生的免疫效应.辐射疗法辐射疗法瘤微环境是一个微环境.超高效率的效率超高的效率.

更多相关视频

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...